Final Program

242 TUESDAY • MAY 17
Target Audience
All clinicians, basic researchers, and other lung health care professionals
looking to learn about state of the art developments in stem cell biology and
their applications to lung diseases
Objectives
At the conclusion of this session, the participant will be able to:
• appreciate the current state of the art with respect to stem cell biology;
• appreciate the current state of the art with respect to cancer stem cells;
• appreciate applications of stem cell and cancer stem cell biology to
respiratory diseases and critical illnesses.
The potential for use of stem cells to prevent or treat human disease has led to
unprecedented growth of the field of regenerative medicine. Moreover,
increasing evidence demonstrates the feasibility of utilizing an individual's own
cells in developing potential stem cell-based therapeutic approaches: the
ultimate in personalized medicine. This symposium will provide a strong basic
scientific and clinical rationale and current state of the art in this rapidly
developing area. The speakers are all accomplished stem cell investigators
from outside the respiratory field who will bring new knowledge and perspective
that will help guide future developments in lung regenerative medicine.
Chairing: D.J. Weiss, MD, PhD, Burlington, VT
D.N. Kotton, MD, Boston, MA
9:00 Normal and Neoplastic Stem Cells
I. Weissman, MD, Stanford, CA
9:30 Imaging Cancer Heterogeneity and Therapy Resistance in Real
Time
T. Reya, PhD, La Jolla, CA
10:00 Interspecific Blastocyst Complementation: A Novel Approach
to Generate Functional Organs
T. Rashid, MD, London United Kingdom
10:30 Defining the Lung Cell By Cell
M. Krasnow, PhD, Palo Alto, CA
C14
MINI SYMPOSIUM
FINDING THE SWEET SPOT BETWEEN TOO MUCH
AND TOO LITTLE CARE
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Chairing: R.S. Wiener, MD, MPH, Boston, MA
A. Garland, MD, MA, Winnipeg, Canada
Oral Presentations
Room 307 (South Building, Esplanade Level)
9:00 ICU Admission Does Not Confer a Survival Benefit for COPD,
CHF, and AMI/T.S. Valley, M.W. Sjoding, A.M. Ryan, T.J.
Iwashyna, C.R. Cooke, Ann Arbor, MI, p.A4556
9:15 Adoption and De-Adoption of Adjuvant Treatments for Acute
Respiratory Failure/L. Munshi, E. Fan, H. Wunsch, H.
Gershengorn, N.D. Ferguson, T. Stukel, G.D. Rubenfeld, Toronto,
Canada, p.A4557
9:30 Hospital Volume and Outcomes of Noninvasive Ventilation in
Patients Hospitalized with an Acute Exacerbation of
COPD/M.S. Stefan, P.K. Lindenauer, M.-S. Shieh, P. Pekow, K.
Fisher, N. Hill, Springfield, MA, p.A4558
9:45 Associations Between Hospital Non-Invasive and Invasive
Mechanical Ventilation Utilization in Acute Exacerbations of
Chronic Obstructive Pulmonary Disease/A.B. Mehta, A.J.
Walkey, Boston, MA, p.A4559
10:00 Gender Differences in Appropriate Treatment for Chronic
Obstructive Pulmonary Disease/S. Rinne, A.H. Gerity, L.M.
Thayer, C.-F. Liu, M.A. Cook, L.A. Bastian, New Haven, CT,
p.A4560
10:15 Diagnosis and Over-Diagnosis of Asthma in Canadian
Adults/S.D. Aaron, K. Vandemheen, L.-P. Boulet, J.M. FitzGerald,
M. Ainslie, S. Gupta, C. Lemiere, S. Field, A. McIvor, P. Hernandez,
I. Mayers, Ottawa, Canada, p.A4561
10:30 Evaluating the Costs of IMRT vs 3D-RT in Stage III Non-Small
Cell Lung Cancer/M.S. Kale, G. Mhango, M. Bonomi, A.
Federman, K. Sigel, K. Rosenzweig, J.P. Wisnivesky, New York,
NY, p.A4562
10:45 Procedural Aggressiveness in Veterans with Stage
IV Non-Small Cell Lung Cancer at End of Life/M.H. Tukey, R.
Youssef, K. Faricy-Anderson, V. Mor, Providence, RI, p.A4563
C15
MINI SYMPOSIUM
TB GAME CHANGERS: DIAGNOSTICS, HIV,
DRUG-RESISTANCE, AND TREATMENT
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Chairing: R. Reves, MD, MSc, Denver, CO
P. Nahid, MD, MPH, San Francisco, CA
C. Daley, MD, Denver, CO
Oral Presentations
Room 3016/3018 (West Building, Level 3)
9:00 Tuberculosis Screening in People Living with HIV Based on
Plasma Cytokine and Chemokine Levels/L.C. Strnad, E. Chang,
L. Chaisson, R.K. Ravindran, P.A. Luciw, I.H. Khan, A.
Cattamanchi, San Francisco, CA, p.A4564
9:15 Intensified Tuberculosis Case-Finding Among People Living
with HIV: Diagnostic Yield of Xpert MTB/RIF, Urine
Lipoarabinomannan and Liquid Culture/C. Yoon, F. Semitala, E.
Atuhumuza, L. Asege, S. Mwebe, J. Katende, A. Andama, D.
Armstrong, D. Dowdy, M. Kamya, A. Cattamanchi, San Francisco,
CA, p.A4565
9:30 Modifiers to the Infectiousness of HIV Seropositive
Tuberculosis Patients: A Household Contact Study from
Sub-Saharan Africa/L. Martinez, J.N. Sekandi, M.E. Castellanos,
S. Zalwango, C.C. Whalen, Athens, GA, p.A4566
9:45 Frequency and Distribution of Tuberculosis
Resistance-Associated Mutations in a Multisite Study/S.B.
Georghiou, D. Catanzaro, R.S. Garfein, V. Crudu, C. Rodrigues,
T.C. Victor, A. Catanzaro, T.C. Rodwell, La Jolla, CA, p.A4567
ATS 2016 • San Francisco